Moving toward a faster, simpler Hendra virus detection system

September 20, 2012
Bottles of quantum dots used to detect Hendra.

(Medical Xpress)—CSIRO scientists, in collaboration with researchers at the Bio21 Institute at the University of Melbourne, have developed a new method which could pave the way for a portable Hendra virus biosensor.

In a paper published in the journal of Advanced Healthcare Materials, CSIRO scientists detail the outcome of the study designed to find a faster, simpler way to detect the .

Hendra virus was discovered in 1994 following an of illness in a large racing stable in the Brisbane suburb of Hendra.

Current detection methods are mainly lab-based and require samples to be shipped to state or national testing labs. CSIRO's tests have shown that this new method can deliver a positive or negative test result, under lab conditions, within 30 minutes. The hope is this can be reduced to ten minutes in the future, making portable detection a reality.

The team tested three new detection methods and found that by using quantum dots - to increase the sensitivity of current analytics methods (assays) - they were able to simplify the detection process to the point where the creation of a portable sensor is now possible.

The method uses a similar principle as a current lab technology, known as Luminex, but the combination of quantum dots and magnetic nano-particles allows the same process to be carried out on a much smaller scale. 

Dr Paolo Falcaro, CSIRO Research Scientist, discusses the science behind the method he has developed to detect the Hendra virus.

"The early detection of viruses, such as the Hendra virus, will greatly enhance the success rate of any biosecurity counter measure," Dr Paolo Falcaro, CSIRO Research Scientist and leader of the joint research team, said.

"Further optimisation of the system is required, but this study is a proof-of-concept of the possibility to implement this method in a portable Hendra virus sensor that could be used at the point of care. The most exciting aspect to this technology is it could be used to detect any other virus by simply targeting the virus with the corresponding antibody."

and magnetic particles were chosen to simplify the reaction required to detect the virus. The works by targeting the and its antibody. If there is a match, the sensor delivers a positive result. 

Professor Paul Mulvaney, of the Bio21 Institute at the University of Melbourne, said: "This is the first application of these fluorescent nanocrystals developed at the University of Melbourne for virus detection and an important example of how the University of Melbourne-CSIRO partnership can help us focus basic science onto important health challenges. Getting this test into a microfluidics platform will enable us to develop a generic approach to pathogen detection in the field."

Explore further: Griffith University tackles deadly Hendra virus

Related Stories

Griffith University tackles deadly Hendra virus

June 4, 2012
Australian medical researchers are on the brink of an effective human treatment for the deadly Hendra virus, and potentially the closely related Nipah virus, which has killed more than two hundred people in South East Asia.

New bat virus could hold key to Hendra virus

August 2, 2012
Australian scientists have discovered a new virus in bats that could help shed light on how Hendra and Nipah viruses cause disease and death in animals and humans. The new virus - named 'Cedar' after the Queensland location ...

Vaccine protects from deadly Hendra virus

May 17, 2011
(Medical Xpress) -- CSIRO scientists have shown that a new experimental vaccine helps to protect horses against the deadly Hendra virus.

Killer Australian virus outbreak claims ninth horse

July 14, 2011
A horse was put down in Australia after contracting the deadly Hendra virus -- the ninth animal to die in an outbreak which has exposed almost 50 people in two states.

Recommended for you

New cellular approach found to control progression of chronic kidney disease

December 15, 2017
Researchers have demonstrated for the first time that extracellular vesicles - tiny protein-filled structures - isolated from amniotic fluid stem cells (AFSCs) can be used to effectively slow the progression of kidney damage ...

Testing shows differences in efficacy of Zika vaccines after one year

December 15, 2017
(Medical Xpress)—A large team of researchers with members from Harvard Medical School, Walter Reed Army Institute of Research, Bioqual Inc. and MIT has found that the efficacy of the three types of Zika vaccines currently ...

How to regulate fecal microbiota transplants

December 15, 2017
(Medical Xpress)—A small team of researchers at the University of Maryland, some with affiliations to the Veterans Affairs Maryland Health Care System, has written and published a Policy Forum piece in the journal Science ...

Screening could catch a quarter of hip fractures before they happen

December 15, 2017
Community screening for osteoporosis could prevent more than a quarter of hip fractures in older women - according to new research led by the University of East Anglia (UEA).

Urine test developed to test for tuberculosis

December 14, 2017
(Medical Xpress)—An international team of researchers has developed a urine test that can be used to detect tuberculosis (TB) in human patients. In their paper published in Science Translational Medicine, the group describes ...

40 years after first Ebola outbreak, survivors show signs they can stave off new infection

December 14, 2017
Survivors of the first known Ebola outbreak, which occurred in the Democratic Republic of the Congo in 1976, may be key to development of vaccines and therapeutic drugs to treat future outbreaks, according to a new study ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.